857
Patients with previously untreated NSCLC were randomized to receive either tirapazamine (390 mg/m(2) infused over 2 hours) followed 1 hour later by cisplatin (75 mg/m(2) over 1 hour) or 75 mg/m(2) of cisplatin alone, every 3 weeks for a maximum of eight cycles.
 Patients with previously untreated NSCLC: Subject; either tirapazamine (390 mg/m(2) infused over 2 hours) followed 1 hour later by cisplatin (75 mg/m(2) over 1 hour) or 75 mg/m(2) of cisplatin alone, every 3 weeks for a maximum of eight cycles: Treatment; tirapazamine: Treatment.Drug; cisplatin: Treatment.Drug; cisplatin: Treatment.Drug; 390 mg/m(2): Treatment.Dosage; 75 mg/m(2): Treatment.Dosage; 75 mg/m(2): Treatment.Dosage; infused: Treatment.Route; over 2 hours: Treatment.Time_elapsed; over 1 hour: Treatment.Time_elapsed; every 3 weeks for a maximum of eight cycles: Treatment.Freq; NSCLC: Treatment.Disorder; tirapazamine: Combination.Drug; cisplatin: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 Patients with previously untreated NSCLC: Subject; either tirapazamine (390 mg/m(2) infused over 2 hours) followed 1 hour later by cisplatin (75 mg/m(2) over 1 hour) or 75 mg/m(2) of cisplatin alone, every 3 weeks for a maximum of eight cycles: Treatment; tirapazamine: Treatment.Drug; cisplatin: Treatment.Drug; cisplatin: Treatment.Drug; 390 mg/m(2): Treatment.Dosage; 75 mg/m(2): Treatment.Dosage; 75 mg/m(2): Treatment.Dosage; infused: Treatment.Route; over 2 hours: Treatment.Time_elapsed; over 1 hour: Treatment.Time_elapsed; every 3 weeks for a maximum of eight cycles: Treatment.Freq; NSCLC: Treatment.Disorder; tirapazamine: Combination.Drug; cisplatin: Combination.Drug